#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10372	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2246	457.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1436	1436	C	545	C	533	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10372	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2246	457.2	0	HET	.	.	.	C207T,A	.	207	207	C	459	459	C	614	C,T,A	478,118,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10372	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2246	457.2	0	HET	.	.	.	C451T,G	.	451	451	C	703	703	C	593	C,T,G	424,154,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18854	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	520.9	0	.	n	.	0	T695C	SNP	695	695	T	1052	1052	C	554	C,T	539,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18854	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	520.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2328	2328	C	578	C,T	563,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18854	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	520.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2402	2402	A	573	A	566	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18854	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	520.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2954	2954	C	597	C,T	584,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1454	folP	855	855	100.0	folP.l15.c4.ctg.1	1575	91.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1077	1079	AGC	163;163;166	A;G;C	158;159;162	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4114	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3550	115.4	1	SNP	p	S91F	1	.	.	271	273	TTC	651	653	TTC	132;132;133	T;T,G;C	131;129,1;130	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4114	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3550	115.4	1	SNP	p	D95G	1	.	.	283	285	GGC	663	665	GGC	130;131;130	G;G;C,A	127;127;126,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4114	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3550	115.4	1	SNP	p	G95N	0	.	.	283	285	GGC	663	665	GGC	130;131;130	G;G;C,A	127;127;126,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1214	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1356	89.1	1	SNP	p	G45D	0	.	.	133	135	GGC	500	502	GGC	155;155;152	G;G;C	150;152;147	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	686	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1070	63.8	0	.	n	.	0	A197.	DEL	197	197	A	636	636	A	155	A	153	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3320	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3085	107.0	0	.	p	.	0	P269S	NONSYN	805	807	CCG	1263	1265	TCG	122;123;120	T;C;G	114;120;115	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3320	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3085	107.0	1	SNP	p	D86N	0	.	.	256	258	GAC	714	716	GAC	127;125;125	G;A,G;C	126;117,1;123	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3320	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3085	107.0	1	SNP	p	R87W	0	.	.	259	261	CGT	717	719	CGT	125;126;127	C;G;T	123;124;120	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3320	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3085	107.0	1	SNP	p	R87I	0	.	.	259	261	CGT	717	719	CGT	125;126;127	C;G;T	123;124;120	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3320	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3085	107.0	1	SNP	p	S87R	1	.	.	259	261	CGT	717	719	CGT	125;126;127	C;G;T	123;124;120	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3320	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3085	107.0	1	SNP	p	S88P	0	.	.	262	264	TCC	720	722	TCC	129;129;128	T;C;C	126;125;125	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2878	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2741	104.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1519	1521	GGC	137;134;132	G;G;C,T	133;129;127,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1280	1282	GCC	155;156;154	G;C;C	152;151;149	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1283	1285	ATG	153;153;154	A;T;G	151;149;151	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1295	1297	ACC	164;163;166	A;C;C	161;162;163	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1295	1297	ACC	164;163;166	A;C;C	161;162;163	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1796	1798	ACC	157;157;157	A;C;C	147;154;154	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1850	1852	GCG	158;158;160	G;C;G	155;156;157	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1850	1852	GCG	158;158;160	G;C;G	155;156;157	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1973	1975	GGT	116;115;114	G;G;T	112;111;106	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1982	1984	AGC	101;100;100	A;G;C	97;99;97	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2932	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2482	117.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2000	2002	CCG	81;82;77	C,G;C,G;G	75,1;74,1;65	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4018	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3090	129.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1609	1611	CCG	146;147;148	C;C;G,C	139;144;138,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1742	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1816	94.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	591	591	C	119	C	117	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1876	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1546	119.6	0	.	p	.	0	E209K	NONSYN	625	627	GAA	910	912	AAA	124;123;126	A;A;A	123;123;126	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1876	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1546	119.6	0	.	p	.	0	A212E	NONSYN	634	636	GCA	919	921	GAA	135;139;136	G;A;A	127;136;134	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1876	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1546	119.6	1	SNP	p	G120K	1	.	.	358	360	AAG	643	645	AAG	161;161;163	A;A;G	156;160;152	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1876	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1546	119.6	1	SNP	p	A121N	1	.	.	361	363	AAC	646	648	AAC	164;163;161	A;A;C	163;162;156	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1876	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1546	119.6	1	SNP	p	N121D	0	.	.	361	363	AAC	646	648	AAC	164;163;161	A;A;C	163;162;156	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6882	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4987	137.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	816	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1014	79.8	1	SNP	p	V57M	1	.	.	169	171	ATG	511	513	ATG	151;153;154	A;T;G	148;151;152	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
